despite neutral imaging results, adalimumab did improve other key markers of inflammation in the blood including glyca, crp, tnf, and il-6. .
-
.
-
.logout
884 Used Today
318 Used Today
80 Used Today
38 Used Today
273 Used Today
despite neutral imaging results, adalimumab did improve other key markers of inflammation in the blood including glyca, crp, tnf, and il-6. .
181 Used Today